講師
- 籌備委員會成員
- 國際委員會
- 公司展望說明會
- Entrepreneur Pitch
- Session 1&2 – Global Biotech Development
- Session 3 –Gap Filling of Health Investment for a Brighter Futur
- Session 4 – How to Bring New Drugs to Global Markets?
- Session 5 – Invest for 2024 and Beyond
- Session 6 - BIO Asia–Taiwan 2023 Opening & Award Ceremony
- Session 7 - Sharing Biotech Successes-Taiwan BIO Awardee Showcas
- Session 8 – Crossing Borders, Establishing a Global Biotech Ecos
- Session 9 – New Asian Age
- Session 10 – Clinical Impacts of Precision Health
- Session 11 – Cell and Gene Therapies with Novel Enabling Platfor
- Session 12 – New Modality Development
- Session 13 – Empowering Patient-centric Digital Health
- Session 14 – Robust Manufacturing for Cell and Biologics
- Session 15 – Biodesign for the Future of MedTech
- Satellite Conference
- 2023 Regional Collaboration Forum
- 2023 Focus Symposia
Samuel Thong
Session 5 – Invest for 2024 and Beyond
Date：26 July (Wednesday)
Time：15:40 – 17:10 (GMT+8)
Samuel Thong
Chairman and Co-Head of Asia Ex-Japan Healthcare Group
Goldman Sachs
Sam is chairman and co-head of Healthcare Investment Banking in Asia Ex-Japan. Sam joined Goldman Sachs in 2019 as a managing director. Previously, he was a senior banker at Morgan Stanley for 12 years in Hong Kong, covering the Asian healthcare sector. Prior to that, Sam covered US healthcare companies at Merrill Lynch in New York for 11 years. He earned a BA in Philosophy, a Doctor of Medicine degree and an MBA, all from the University of Chicago.
